These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3309546)

  • 1. Impaired glucose handling in active rheumatoid arthritis: effects of corticosteroids and antirheumatic treatment.
    Svenson KL; Lundqvist G; Wide L; Hällgren R
    Metabolism; 1987 Oct; 36(10):944-8. PubMed ID: 3309546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired glucose handling in active rheumatoid arthritis: relationship to the secretion of insulin and counter-regulatory hormones.
    Svenson KL; Lundqvist G; Wide L; Hällgren R
    Metabolism; 1987 Oct; 36(10):940-3. PubMed ID: 3309545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired glucose handling in active rheumatoid arthritis: relationship to peripheral insulin resistance.
    Svenson KL; Pollare T; Lithell H; Hällgren R
    Metabolism; 1988 Feb; 37(2):125-30. PubMed ID: 2893241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic effects of high-dose prednisolone treatment in early rheumatoid arthritis: balance between diabetogenic effects and inflammation reduction.
    den Uyl D; van Raalte DH; Nurmohamed MT; Lems WF; Bijlsma JW; Hoes JN; Dijkmans BA; Diamant M
    Arthritis Rheum; 2012 Mar; 64(3):639-46. PubMed ID: 21953589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of disease-modifying antirheumatic drugs versus cytotoxic agents in the therapy of rheumatoid arthritis.
    Ward JR
    Am J Med; 1988 Oct; 85(4A):39-44. PubMed ID: 3052055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum lipoprotein in active rheumatoid arthritis and other chronic inflammatory arthritides. II. Effects of anti-inflammatory and disease-modifying drug treatment.
    Svenson KL; Lithell H; Hällgren R; Vessby B
    Arch Intern Med; 1987 Nov; 147(11):1917-20. PubMed ID: 3675092
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-modifying drugs for progressive rheumatoid arthritis.
    Bunch TW; O'Duffy JD
    Mayo Clin Proc; 1980 Mar; 55(3):161-79. PubMed ID: 6766523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis.
    Gotzsche PC; Johansen HK
    Cochrane Database Syst Rev; 2003; (1):CD000189. PubMed ID: 12535392
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum osteocalcin in rheumatoid arthritis and other inflammatory arthritides: relation between inflammatory activity and the effect of glucocorticoids and remission inducing drugs.
    Ekenstam EA; Ljunghall S; Hällgren R
    Ann Rheum Dis; 1986 Jun; 45(6):484-90. PubMed ID: 3015056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacology of antirheumatic drugs.
    Parnham MJ
    Agents Actions Suppl; 1984; 14():153-69. PubMed ID: 6382972
    [No Abstract]   [Full Text] [Related]  

  • 11. Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis.
    Gotzsche PC; Johansen HK
    Cochrane Database Syst Rev; 2002; (2):CD000189. PubMed ID: 12076385
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis.
    Gotzsche PC; Johansen HK
    Cochrane Database Syst Rev; 2000; (2):CD000189. PubMed ID: 10796316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Short-term low-dose corticosteroids vs placebo and nonsteroidal antiinflammatory drugs in rheumatoid arthritis.
    Gotzsche PC; Johansen HK
    Cochrane Database Syst Rev; 2001; (2):CD000189. PubMed ID: 11405954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of disease-modifying anti-rheumatic drugs, steroids and non-steroidal anti-inflammatory drugs on acute-phase proteins in rheumatoid arthritis.
    Menkes CJ
    Br J Rheumatol; 1993 Jun; 32 Suppl 3():14-8. PubMed ID: 7685225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of glucocorticoids in rheumatoid arthritis].
    Jacobsen S
    Ugeskr Laeger; 2000 Feb; 162(6):770-2. PubMed ID: 10689949
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current status of drug therapy in chronic polyarthritis].
    Seitz M
    Ther Umsch; 1991 Sep; 48(9):613-23. PubMed ID: 1683020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rheumatoid arthritis: a pharmacologic overview.
    Pinals RS
    Am Fam Physician; 1988 Mar; 37(3):145-52. PubMed ID: 2894754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone loss in rheumatoid arthritis and primary generalized osteoarthrosis: effects of corticosteroids, suppressive antirheumatic drugs and calcium supplements.
    Reid DM; Kennedy NS; Smith MA; Nicoll J; Brown N; Tothill P; Nuki G
    Br J Rheumatol; 1986 Aug; 25(3):253-9. PubMed ID: 3730735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis.
    Singh G; Fries JF; Williams CA; Zatarain E; Spitz P; Bloch DA
    J Rheumatol; 1991 Feb; 18(2):188-94. PubMed ID: 1673721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral blood T lymphocyte subsets in active rheumatoid arthritis--effects of different therapies on previously untreated patients.
    Karlsson-Parra A; Svenson K; Hällgren R; Klareskog L; Forsum U
    J Rheumatol; 1986 Apr; 13(2):263-8. PubMed ID: 3088273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.